Skip to main content

Closed

APLM: Apollomics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+4192.9% / yr

Operating margin-111.4%

ROIC-1586.8%

Financially safe

Stretched

Debt / equity-0.20×

Interest coverage-145.7×

Current ratio0.96×

Apollomics, Inc.

APLMNASDAQ Capital Market·USD·Closed

Apollomics, Inc.

APLMNASDAQ·USD·Closed

$17.25

−0.61%

$17.25

−$0.11 (0.61%)

52W Range

35thpctl

Volume

0.29×avg

Mkt Cap

19.03MUSD

P/E

-2.3TTM

Div Yield

–ann

52W Range

35thpctl

Volume

0.29×avg

Market Cap

19.03MUSD

P/E Ratio

-2.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings